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428Objectives: Concomitant surgical ablation is a safe and feasible procedure, recommended by the guidelines for
patients with atrial fibrillation (AF) undergoing cardiac surgery. We performed a single-center data analysis to
identify the predictors of rhythm outcome in such patients.
Methods: From January 2003 to January 2012, 503 patients with persistent (n ¼ 296, 58.8%) or paroxysmal
(n ¼ 207, 41.2%) AF underwent concomitant surgical AF ablation. The lesions were limited to a pulmonary
vein isolation (n ¼ 76, 15.1%), a more complex left atrial lesion set (n ¼ 353, 70.2%), or biatrial lesions
(n ¼ 74, 14.7%). Follow-up rhythm evaluations were based on either 24-hour Holter electrocardiograms or
event recorder interrogation at 3, 6, and 12 months postoperatively. A sinus rhythm (SR) immediately
postoperatively was defined as the first documented rhythm after weaning from extracorporeal circulation.
Results: The mean patient age was 68.0  9.5 years, and 336 (66.8%) were men. No major ablation-related
complications occurred. After 1 year of follow-up, 59.9% of all patients were in SR, with significantly better
results in patients with paroxysmal AF than in those with persistent AF (67.3% vs 54.8%, P ¼ .0053).
Additional statistically significant factors influencing SR after 1 year were left atrial diameter (P ¼ .0019),
AF duration (P ¼ .018), and immediate postoperative SR (P<.001). Regarding only patients with persistent
or longstanding-persistent AF, those with biatrial lesions had significantly greater rates of conversion to SR
than those with solitary left atrial ablation (SR, 64.9% vs 51.4%; P ¼ .044) after 12 months.
Conclusions: The statistically significant predictors for SR after 1 year were left atrial diameter,
AF duration, preoperative paroxysmal AF, immediate postoperative SR, and biatrial ablation for persistent
AF. (J Thorac Cardiovasc Surg 2014;148:428-33)Atrial fibrillation (AF) is the most common sustained
arrhythmia in patients undergoing cardiac surgery, and its
prevalence has been increasing with the aging of
populations. AF can lead to heart failure, thromboembolic
events, including stroke, and increased hospitalization,
with a reduction in quality of life.1,2 Therefore, the
guidelines have recommended concomitant surgical
ablation for patients with AF who are undergoing cardiac
surgery.3 Cox first reported his technique of surgical AF
ablation using a cut-and-sew principle in 1987, later revised
by him to a lesion pattern termed the ‘‘Cox maze III
procedure.’’ Because of its high success rate in the
restoration of sinus rhythm (SR), it became the reference
standard for AF surgery. However, owing to complexity
of the procedure, only a few surgeons were performing it.e Department of Cardiovascular Surgery, University Heart Center Hamburg,
urg, Germany.
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The Journal of Thoracic and Cardiovascular SurgTo facilitate and simplify the procedure, the cut and sew
principle was replaced by transmural atrial lesions
generated by various thermal energy sources, such as
radiofrequency, ultrasonography, or cryotherapy, resulting
in the so-called Cox maze IV procedure. Various modified
lesion sets, including isolated pulmonary vein ablation,
left atrial ablation, and biatrial ablation, have been reported
over the years. A meta-analysis by Barnett and Ad4 showed
that in randomized controlled trials and nonrandomized
trials, statistically greater rates of conversion to SR
occurred in patients who had undergone cardiac surgery
with concomitant ablation compared with those who had
undergone cardiac surgery alone. Prospective, randomized
trials have resulted in rates of conversion to SR of 44% to
94% for patients undergoing concomitant AF ablation.5-9
However, only a few studies with relatively small
numbers of patients have investigated the influence of
different lesion sets and energy sources on the outcomes
of surgical AF ablation. Therefore, the aim of our study
was to analyze the predictors of the 12-month outcome in
patients with AF who had undergone concomitant surgical
ablation and to determine the effect of different patient
factors, energy sources, and lesion sets on the rates of
conversion to SR in a large patient cohort with implementa-
tion of the current follow-up guidelines.ery c August 2014
Abbreviations and Acronyms
AF ¼ atrial fibrillation
CABG ¼ coronary artery bypass grafting
ECG ¼ electrocardiogram
ER ¼ event recorder
LA ¼ left atrial
LVEF ¼ left ventricular ejection fraction
PVI ¼ pulmonary vein ablation
SR ¼ sinus rhythm
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Patients
From January 2003 to October 2011, 503 patients underwent
concomitant surgical ablation because of persistent (n ¼ 296, 58.8%) or
paroxysmal (n ¼ 207, 41.2%) AF. The baseline patient characteristics
are listed in Table 1. The mean patient age was 68.0  9.5 years, and
66.8% were men. Of the 503 patients, 296 (58.8%) had preoperative
persistent AF and 207 (41.2%) had paroxysmal AF. The mean left atrial
(LA) diameter was enlarged to 51.0 mm, and the mean left ventricular
ejection fraction (LVEF) showed a normal value of 53.5%. A moderate
or more severely reduced LVEF of<40% was present in 61 patients
(12.1%). The mean AF duration was 3.4 years, and 51 patients (10.2%)
had a experienced a thromboembolic or ischemic stroke before surgery.
The surgical procedures are listed in Table 2.
Ablation Methods
The ablation types are listed in Table 3. Isolated pulmonary vein
ablation (PVI) was conducted in 76 patients (15.1%). This limited lesion
set was used in patients with paroxysmal AF and without planned opening
of the atria for the surgical procedure (eg, in patients undergoing coronary
artery bypass grafting [CABG] and aortic valve replacement). Extended
LA ablation was performed in 353 patients (70.2%) using the LA ablation
lesion set of the Coxmaze IV procedure, with pulmonary vein ablation, box
lesion, LA appendage, and isthmus isolation. Since 2008, biatrial ablation
was conducted in 74 patients (14.7%). This extended ablation regimen was
only conducted in patients with persistent or longstanding-persistent AF.
The decision of which patients underwent a biatrial or LA lesion set was
determined by the surgeon performing the procedure. The right atrial lesion
set consisted of intercaval line, isolation of the cavotricuspid isthmus, right
atrial appendage, and terminal crest.
The energy sources were argon-based cryoablation in 114 patients
(22.7%; CryoCath Surgical Ablation Probe, Medtronic, Inc, Minneapolis,
Minn; and CryoICE Cryoablation probe, Atricure, Inc, West Chester,
Ohio), unipolar radiofrequency ablation in 261 (51.8%; CardioblateUnipolar
RF Pen, Medtronic), and bipolar radiofrequency ablation in 128 (25.5%;
CardioblateBP2device andCardioblateSurgicalAblationSystemGenerator,
Medtronic; and Atricure Isolater Synergy Ablation Clamp, Atricure). From
2003 to 2009, epimyocardial cryoablation was used in patients receiving
surgical AF ablation without opening the left atrium; all other patients
received endomyocardial ablation using unipolar radiofrequency. Since
2009, after introduction of the bipolar radiofrequency clamp in our institution,
it has become the preferred tool for all strategies of ablation. Since then,
endomyocardial unipolar radiofrequency or cryoablation has only been
used in patients requiring mitral valve treatment with either an open sternum
transseptal or a minimally invasive thoracic-lateral approach.Statistical Analysis
A retrospective, single-center data analysis was accomplished.
All statistical analyses were performed using the Statistical Package forThe Journal of Thoracic and CaSocial Sciences statistical software, version 18.0 (SPSS, Inc, Chicago,
Ill). Continuous values are presented as mean  standard deviation and
were compared using the Student t test. Categorical variables are presented
as the frequencies and percentages and were compared using the chi-square
test or Fisher’s exact test, as appropriate. P < .05 was considered
statistically significant. The reported P values are 2-sided. Uni- and
multivariate logistic regression analyses were used to identify independent
predictors for SR after 12months. The parameters considered for univariate
analysis were age, gender, LA diameter, AF type and duration, LVEF, type
of concomitant procedure, lesion set, energy source, and early AF
recurrence. For multivariate logistic regression analysis, we included the
significant covariates from the univariate analysis and the covariates that
in our experience had been considered clinically relevant. These were
age, gender, AF type and duration, surgical procedure, LVEF, and LA
diameter.
Follow-up Protocol
Rhythm follow-up was accomplished after 3, 6, and 12 months in all
patients using either 24-hour Holter electrocardiograms (ECGs)
(n ¼ 353) or event recorder (ER) interrogation (n ¼ 149). In patients
with ER, AF recurrence was defined as an AF burden> 0.5% and/or a
duration of a single AF episode of>30 s. ER-documented AF episodes
were manually validated. In patients without ER, a 24-hour Holter ECG
was recorded at 3, 6, and 12 months postoperatively. In the latter group,
any episode of AF with a duration>30 s was regarded as AF recurrence.
Antiarrhythmic drugs and anticoagulation regimens were maintained for
3 months postoperatively in all patients and then adapted according to
the ER or 24-hour ECG rhythm results. In patients without a contraindica-
tion, amiodarone was used as the first-line antiarrhythmic therapy.
Otherwise, other class I or class III antiarrhythmic drugs were
prescribed for3 months postoperatively. Antiarrhythmic medical therapy
was stopped when the patients were in SR at 3 months of follow-up.
Electrical cardioversion was performed in patients with persistent AF at
the follow-up examination. Patients with AF recurrence at 6 months
postoperatively were considered for additional catheter-based ablation,
if reasonable. Patients receiving additional catheter-based ablation were
considered to have failure of surgical AF ablation for rhythm analysis after
12 months.
RESULTS
Perioperative Data and Outcomes
No major ablation-related complication occurred in any
of the patients. A perforation of the posterior wall of the
left atrium was present in 1 patient after cryoablation
and was sutured without additional complications. No
intraoperative deaths occurred. Five patients (0.9%)
experienced perioperative stroke. The in-hospital mortality
was 1.2%, and the 1-year survival rate was 94.9%. The
stroke-free survival rate after 1 year was 97.2%.
Concomitant procedures and ablation type are listed in
Table 2. Most procedures included mitral (n ¼ 151,
30.0%) or aortic valve (n ¼ 53, 10.5%) surgery. CABG
was performed in 126 patients (25.1%), tricuspid valve
replacement in 8 patients (1.6%), and aortic surgery in 14
patients (2.0%). Combined mitral valve replacement and
tricuspid valve replacement was performed in 46 patients
(9.2%), mitral valve replacement and aortic valve
replacement in 25 (5.0%), and mitral valve replacement
plus CABG in 58 (11.5%). Other procedures were
conducted in 22 patients (4.4%).rdiovascular Surgery c Volume 148, Number 2 429
TABLE 1. Patient characteristics (n ¼ 503)
Characteristic Value
Age (y) 68.0  9.5
Gender
Female 336
Male 167
AF duration (y) 4.0  3.7
Paroxysmal AF 207 (41.2)
Persistent AF 296 (58.8)
LA diameter (mm) 51.0  8.9
LVEF (%) 52.6  11.0
LVEF<40% 61 (12.1)
Previous stroke 51 (10.1)
Diabetes 95 (18.9)
Renal insufficiency 55 (10.9)
Preoperative pacemaker use 34 (6.8)
Peripheral arterial disease 29 (5.8)
COPD 51 (10.1)
Coronary artery disease 240 (47.7)
Previous MI 50 (9.9)
Data presented as mean  standard deviation or n (%). AF, Atrial fibrillation;
LA, left atrial; LVEF, left ventricular ejection fraction; COPD, chronic obstructive
pulmonary disease; MI, myocardial infarction.
TABLE 3. Types of ablation (n ¼ 503)
Ablation type n (%)
Cryoablation 114 (22.7)
Radiofrequency 389 (77.3)
Unipolar 261 (51.9)
Bipolar 128 (25.4)
LA 353 (70.2)
Biatrial 74 (14.7)
PVI 76 (15.1)
LA, Left atrial; PVI, pulmonary vein ablation.
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The completeness of follow-up was 96% after 12
months. The overall rate of conversion to SR was 49.8%,
57.6%, and 59.9% after 3, 6, and 12 months, respectively
(Figure 1). In patients with preoperative paroxysmal
AF, the rate of conversion to SR after 12 months was
significantly greater than that in patients with persistent
AF (SR, 67.3% vs 54.8%; P ¼ .0053). The rate of
registered SR did not differ significantly between the ER
and Holter-monitored patients after 12 months (63.2% vs
58.5%). Neither demographic data nor the type of
concomitant procedure nor pre-existing disease had a
significant effect on SR after 1 year (Table 4).
Radiofrequency ablation was used in 389 patients
(77.3%), either unipolar (n ¼ 261) or bipolar (n ¼ 128),
with a 57.3% conversion rate to SR in the unipolar and
62.7% conversion rate to SR in the bipolar group
(Figure 2). Between the 2 groups, no significant differences
were found in the preoperative AF type, with 38.2%TABLE 2. Surgical procedures (n ¼ 503)
Procedure n (%)
CABG 130 (32.4)
AVR 153 (38.2)
MVR 202 (50.4)
TVR 47 (11.7)
MVR plus TVR 50 (9.9)
MVR plus CABG 50 (9.9)
MVR plus AVR 39 (7.8)
Aortic surgery 24 (4.8)
CABG, Coronary artery bypass grafting; AVR, aortic valve replacement;
TVR, tricuspid valve replacement; MVR, mitral valve replacement.
430 The Journal of Thoracic and Cardiovascular Surgparoxysmal AF in the unipolar and 44.3% in the bipolar
group (P ¼ .12). Cryoablation was performed in 114
patients (22.7%), with a 60.7% conversion rate to SR.
All together, the type of energy source used did not
significantly influence the restored SR rate after 12 months.
Complete left-sided ablation was accomplished in 353
patients (70.2%), and pulmonary vein isolation only was
conducted in 76 (15.1%). PVI was only used in patients
with paroxysmal AF. In the population with paroxysmal
AF, no statistically significant difference was found in the
SR rate after 12 months between patients with a complete
LA lesion set and those with only PVI (69.3% vs 64.4%,
P ¼ .43; Figure 3). In the 296 patients with persistent and
longstanding-persistent AF, those with biatrial lesion sets
had significantly greater rates of SR after 1 year than the
LA ablation group (SR, 64.9% vs 51.4%; P ¼ .044;
Figure 4). Additional predictors for SR after 12 months
were the LA diameter and AF duration. Patients with a
smaller LA diameter (P ¼ .0019) and shorter AF duration
(P ¼ .018) had significantly greater rates of SR after 1
year. Stratifying the patients into groups with different LA
diameters, patients with an LA diameter< 5 cm, 5 to 6
cm, and>6 cm had a sinus rhythm rate of 66.2%, 59.3%,
and 44.1%, with a statistically significant lower SR rate
in patients with an LA diameter> 6 cm (P< .001). SR
immediately postoperatively (68.6% SR after 1 year,
P<.001) was an independent predictor of SR after 1 year.FIGURE 1. Sinus rhythm rate during follow-up.
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TABLE 4. Influence of patient factors and procedures on sinus rhythm
rate after 12 months by multivariate logistic regression analysis
Variable P value
Age (y) .723
Male gender .179
Paroxysmal AF .005*
LA diameter .002*
AF duration .019*
Coronary artery disease .155
Preoperative LVEF .256
CABG .058
AVR .266
MVR .096
Cryoablation .837
Radiofrequency unipolar .218
Radiofrequency bipolar .277
LA lesion set .308
PVI .859
Biatrial lesion set .343
Immediate postoperative SR <.001*
AF, Atrial fibrillation; LA, left atrial; LVEF, left ventricular ejection fraction;
CABG, coronary artery bypass grafting; AVR, aortic valve replacement; MVR, mitral
valve replacement;PVI, pulmonary vein ablation; SR, sinus rhythm. *Paroxysmal AF,
.0053; LA diameter, .0019; AF duration, .018; immediate postoperative SR, .001.
FIGURE 3. Sinus rhythm rate during follow-up in patients with
paroxysmal atrial fibrillation (AF). LA, Left atrial; PVI, pulmonary vein
ablation.
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patients (5.2%), and electrical cardioversion was conducted
in 54 patients (10.7%) within 1 year of follow-up.
DISCUSSION
The original Cox maze procedure, first reported by Cox
in 1987, was revised to the Cox maze III procedure, which
became the reference standard for AF ablation. In many
comparisons, the Cox maze III procedure has been reported
to be the most effective therapy for AF, resulting in success
rates of 99%.10,11 Replacing the original cut and sew
principles by ablation with different energy sources toFIGURE 2. Sinus rhythm rate stratified by different energy sources.
The Journal of Thoracic and Cacreate transmural thermal atrial lesions led to the Cox
maze IV procedure. This modified Cox maze procedure
has been shown to be as effective as the classic cut and
sew maze technique. Lall and colleagues12 showed similar
results in a propensity score-matched analysis for patients
undergoing the Cox maze III and IV procedures, with a
success rate of 96% and 93%, respectively, after 1 year
of follow-up. Surgical AF ablation can be conducted either
as a standalone or concomitant procedure. In the present
study, we have reported our experience with surgical AF
ablation as a concomitant procedure.
To date, 6 prospective randomized trials have reported
the results of concomitant surgical ablation for patients
with AF. The largest trial included 97 patients withFIGURE 4. Sinus rhythm rate during follow-up in patients with persistent
atrial fibrillation (AF).
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The patients were randomized to either mitral valve
surgery and LA radiofrequency ablation or mitral valve
surgery only. Patients with concomitant ablation showed
significantly greater rates of SR after 1 year (44% vs
4.5%).9 This finding was replicated in other prospective
randomized trials.5-8 The rates of SR ranged from 57% to
82% in these studies. However, because of the small
number of patients and the resulting limited statistical
power, none of the randomized trials was able to show a
survival benefit for patients receiving concomitant
ablation. However, in a recent propensity score-matched
analysis by McCarthy and colleagues,13 the midterm
survival of patients with AF receiving concomitant surgical
ablation was significantly greater statistically compared
with the untreated patients and comparable to those of
patients without preoperative AF.
Great variability was also found in the ablation success
rates in recent retrospective studies, with SR rates
ranging from 67% to 84% in patients with AF undergoing
concomitant surgical ablation.14-20 These variations were
most likely the result of the use of different lesion sets,
energy sources, surgeon experience, and implemented
follow-up strategies, which varied from symptom-oriented
patient interviews to continuous rhythm monitoring.
Our retrospective data series contained a large number of
patients treated during a long period and using different line
sets and energy sources for AF ablation. We found that the
energy source type used for ablation did not have any effect
on SR after 12 months, which has also been seen in
previously published studies.20,21 However, a few reports,
although none prospective, have been published reporting
that the success of ablation depended on energy source
used.
Regarding the different lesion sets, a study by Gillinov
and colleagues14 and a meta-analysis by Barnett and Ad4
have shown biatrial lesion sets to be superior to LA lesion
sets in patients with persistent AF. This finding was
supported in our series in the multivariate analysis when
assessing only patients with persistent AF. A significantly
greater SR rate was seen in patients with biatrial lesion
sets than in those receiving only LA ablation. However, a
greater incidence of postoperative permanent pacemaker
implantation was observed in patients receiving a biatrial
lesion set in a study by Worku and colleagues22 and in
our previously published data.23
The present study is 1 of the first series to implement the
recent guidelines for follow-up.3 All rhythm results
were collected using either 24-hour Holter ECG or ER
interrogation. All patients had 1 24-hour Holter ECG or
ER interrogation at 3 and 12 months of follow-up.
Especially in patients with paroxysmal AF, this allowed a
more accurate analysis of the actual rhythm and ablation
success rates. Previous studies have shown that short-term432 The Journal of Thoracic and Cardiovascular Surgrhythm monitoring underestimates the rate of AF recur-
rence after ablation therapy,24,25 and the more extended
follow-up period might have been the reason for the lower
SR rates compared with the previously published
results of surgical AF ablation with less extensive follow-
up strategies. Gillinov and colleagues14 reported in a
retrospective study a rate of SR of 76% at 1 year after sur-
gical AF ablation in patients with persistent AF. However,
the rhythm results were based only on the ECG findings,
and the conversion rate might have been lower if the results
had included repeated 24-hour Holter ECG or continuous
rhythm monitoring using ER.
On multivariate analysis, no association was found
between gender, age, coronary artery disease, LVEF, and
the type of concomitant procedure and the rates of SR after
1 year. In previously published studies,14,17 older age
resulted in a greater rate of AF recurrence; however, we
could not confirm this finding in our study.
In the present study, a LA diameter > 6 cm was an
independent predictor for successful ablation. Similar
observations were reported by Damiano and colleagues15
and Gillinov et al.18,19 The AF duration was also an
independent predictor of greater rates of SR after 1 year.
This result was supported in a previous study by Gaynor
and colleagues16 but could not be confirmed in their more
recent analysis for predictors of late recurrence in Cox
maze IV procedures.
Immediate postoperative SR was an independent
predictor of ablation success after 12 months. Similar
results have been published by Damiano and colleagues.15
They found that patients with early recurrence of atrial
tachycardias also had greater rates of AF recurrence after
1 year.15 All our patients received amiodarone for 3 months
postoperatively. It remains unknown whether a more
extensive cardioversion regimen with additional electrical
cardioversion in patients with early recurrence of atrial
tachycardia would have improved the long-term outcomes,
although it is probable that early recurrence of atrial
tachycardia is also evidence for the presence of an
additional pathologic atrial substrate that maintains these
arrhythmias. Additional investigation is needed to address
this question.
Our success rates were significantly greater in patients
with preoperative paroxysmal AF than in those with
persistent AF, just as previously published,14,18,19 and
was not surprising. In patients with paroxysmal AF,
reentry circuits play a major role, and a pathologic
substrate available to sustain atrial tachyarrhythmias is
likely less.26
Amajor limitation of the present study was that we used a
nonrandomized retrospective study design, in which
unknown confounders and selection and detection bias
could not be completely avoided. Furthermore, the present
study was a single-center analysis.ery c August 2014
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conversion rate of 59.9% after 1 year of follow-up. The
statistically significant predictors for SR after 1 year were
preoperative paroxysmal AF, LA diameter, AF duration,
and SR immediately postoperatively. In patients with
persistent AF, those receiving a biatrial lesion set showed
a statistically significant greater SR conversion rate after
12 months of follow-up. However, different energy sources
and the type of concomitant procedure did not influence the
SR rate.
Because of previously published data and our own
experience, our current ablation strategy includes a biatrial
lesion set in patients with persistent AF. In most patients
with paroxysmal AF, a complete LA lesion set is performed,
and only PVI is performed in patients undergoing off-pump
CABG and some of the patients undergoing aortic valve
replacement or CABG without opening the left atrium.
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